COMMENT LES FABRICANTS DE LAITS INFANTILES FONT PASSER LEURS PROFITS AVANT LA SANTÉ DES NOURRISSONS

The report analyzes over 400 infant formula products from Nestlé, Danone, Mead Johnson Nutrition, and Abbott. It finds that these companies use product differentiation and 'premium' branding to increase profit margins, particularly in Asian markets, without clear scientific justification for the variety of products offered. The study highlights significant price disparities between countries and a reliance on industry self-regulation for nutritional quality.

• The nutritional quality of infant formula relies heavily on industry self-regulation, with limited government supervision of compliance with regulatory standards, despite reports of pathogenic microorganisms like Enterobacter sakazakii and Salmonella spp. in powder products.
• Major manufacturers offer an extensive range of products—over 400 identified—including those with non-legally required nutrients (such as DHA, ARA, prebiotics, and probiotics) or claims to treat general ailments, which the report asserts lacks a clear scientific basis.
• Product differentiation is used as a tool to increase prices and profit margins, leading to extreme cost disparities. In Indonesia, the most expensive formula found (Enfamil A+) is 4.5 times the price of the most economical brand (SGM Ananda Presinutri 1).
• The same brand of infant formula is sold at vastly different prices across different countries. For example, Aptamil Profutura 1 (Danone) is approximately three times more expensive in China (approx. 55 USD) than in the UK (approx. 17 USD).
• The cost of 'premium' infant formula places a severe financial burden on families in Asia. In China, these products can cost nearly 40% of the average monthly salary, and in Indonesia, a parent earning the average salary could spend up to three-quarters of their monthly income on Enfamil A+.
• The report concludes that product development is guided by market research into consumer preferences and willingness to pay rather than nutritional science, noting that companies' product lines often resemble their competitors' in a specific market more than their own products in other markets.

APA

Changing Markets Foundation (n.d.). COMMENT LES FABRICANTS DE LAITS INFANTILES FONT PASSER LEURS PROFITS AVANT LA SANTÉ DES NOURRISSONS. https://changingmarkets.org/wp-content/uploads/2023/10/CM-MILKING-IT-SUMMARY-French.pdf

Chicago

Changing Markets Foundation. COMMENT LES FABRICANTS DE LAITS INFANTILES FONT PASSER LEURS PROFITS AVANT LA SANTÉ DES NOURRISSONS. n.d. https://changingmarkets.org/wp-content/uploads/2023/10/CM-MILKING-IT-SUMMARY-French.pdf.

Wikipedia

{{cite report |author=Changing Markets Foundation |title=COMMENT LES FABRICANTS DE LAITS INFANTILES FONT PASSER LEURS PROFITS AVANT LA SANTÉ DES NOURRISSONS |url=https://changingmarkets.org/wp-content/uploads/2023/10/CM-MILKING-IT-SUMMARY-French.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{changingmarketsfoundationndcomment, author = {{Changing Markets Foundation}}, title = {{COMMENT LES FABRICANTS DE LAITS INFANTILES FONT PASSER LEURS PROFITS AVANT LA SANTÉ DES NOURRISSONS}}, institution = {Changing Markets Foundation}, url = {https://changingmarkets.org/wp-content/uploads/2023/10/CM-MILKING-IT-SUMMARY-French.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }